Biofrontera AG ADR (BFRA)

5.510
+0.040(+0.73%)
After Hours
5.430
+0.008(+0.148%)
- Real-time Data
  • Volume:
    1,747
  • Bid/Ask:
    5.400/5.660
  • Day's Range:
    5.420 - 5.610

BFRA Overview

Prev. Close
5.47
Day's Range
5.42-5.61
Revenue
-
Open
5.43
52 wk Range
4.67-9.67
EPS
-
Volume
1,747
Market Cap
158.71M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
7,991
P/E Ratio
-
Beta
-
1-Year Change
-32.47%
Shares Outstanding
56,717,385
Next Earnings Date
Nov 30, 2021
What is your sentiment on Biofrontera AG ADR?
or
Market is currently closed. Voting is open during market hours.

Biofrontera AG ADR News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsSellNeutralStrong BuyNeutralStrong Sell
SummaryNeutralBuyStrong BuyNeutralStrong Sell

Biofrontera AG ADR Company Profile

Biofrontera AG ADR Company Profile

Employees
154

Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin. Its principal product is Ameluz, a prescription drug for the treatment of lesion-directed and field-directed actinic keratosis. The company also offers BF-RhodoLED lamp, a photodynamic therapy for lesion-directed and field-directed treatment of actinic keratosis; and Belixos, an over-the-counter line of skin care cosmetic products. In addition, it is developing Ameluz for the treatment of field cancerization and nodular basal cell carcinoma. Further, the company’s product portfolio includes Xepi, a prescription antibiotic cream for the treatment of impetigo; and Aktipak, a generic drug for the treatment of acne. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

Read More
  • Time to buy
    0
    • Rocket
      0
      • is it goes up to 12 or not?
        0
      • 0
    • Ready for rocket by next week
      0
      • Should be up for next a couple days
        1
        • Back to $11 soon
          0
          • when??? :/
            0
          • Nov
            0
        • No idea what happened to this stock...! Behaved like a SCAM
          0
          • Any news or chance to go up or not?
            0
            • Any positive news or chance to go up or not?
              0
              • Any positive news or chance to go up or not?
                0
                • Captain Speaking....Cabincrew get ready for Take off & Rocketdrive 🚀
                  0
                  • Any news or chances to go up?
                    0
                • what happen?
                  0
                  • strong buy...
                    0
                    • Premarket ROCKETDRIVE 🚀
                      0
                      • lets go boysss
                        1
                        • Very legal, very cool
                          0
                          • LOL, what happened to this stock
                            0
                            • gonna go straight back down, be very weary
                              0
                              • why?
                                0
                            • i was about to go in at more than 400% but didnot, bad idea for me
                              0
                              • nah good idea. don't chase greed when something is that high. youll get burnt 9 times out of 10
                                0
                            • does anyone made profit from this stock ?
                              0
                              • I did
                                0
                            • no news
                              0
                              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.